Partner Fund Management
Latest statistics and disclosures from PFM Health Sciences's latest quarterly 13F-HR filing:
- Top 5 stock holdings are LLY, THC, XBI, AXSM, MCK, and represent 35.19% of PFM Health Sciences's stock portfolio.
- Added to shares of these 10 stocks: XBI (+$72M), UTHR (+$25M), UHS (+$24M), CNC (+$21M), MRK (+$20M), ELV (+$20M), ADMA (+$17M), RVMD (+$16M), VERA (+$15M), BSX (+$15M).
- Started 26 new stock positions in XBI, WST, AMRX, CGON, VEEV, HIMS, CNC, VERA, RYTM, RVMD.
- Reduced shares in these 10 stocks: LLY (-$33M), DHR (-$32M), , , , INDV (-$19M), TEVA (-$18M), MASI (-$16M), Ascendis Pharma A/s (-$16M), ASND (-$15M).
- Sold out of its positions in ABBV, ALNY, BMRN, BPMC, DHR, ERAS, HOLX, IOBT, MASI, MOH. SGMT, UNH.
- PFM Health Sciences was a net buyer of stock by $41M.
- PFM Health Sciences has $1.3B in assets under management (AUM), dropping by 10.72%.
- Central Index Key (CIK): 0001442756
Tip: Access up to 7 years of quarterly data
Positions held by Partner Fund Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for PFM Health Sciences
PFM Health Sciences holds 70 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Eli Lilly & Co. (LLY) | 13.2 | $172M | -16% | 225k | 763.00 |
|
| Tenet Healthcare Corp Com New (THC) | 7.2 | $94M | -7% | 462k | 203.04 |
|
| Spdr Series Trust S&p Biotech Call Option (XBI) | 5.5 | $72M | NEW | 717k | 100.20 |
|
| Axsome Therapeutics (AXSM) | 5.0 | $64M | +9% | 530k | 121.45 |
|
| McKesson Corporation (MCK) | 4.3 | $56M | 72k | 772.54 |
|
|
| Penumbra (PEN) | 3.8 | $49M | +17% | 195k | 253.32 |
|
| United Therapeutics Corporation (UTHR) | 3.1 | $40M | +162% | 96k | 419.21 |
|
| Intuitive Surgical Com New (ISRG) | 2.7 | $35M | -12% | 77k | 447.23 |
|
| Edwards Lifesciences (EW) | 2.3 | $30M | -2% | 381k | 77.77 |
|
| Humana (HUM) | 2.3 | $30M | +3% | 114k | 260.17 |
|
| Ascendis Pharma A/s Sponsored Adr (ASND) | 2.2 | $29M | -34% | 145k | 198.81 |
|
| Hca Holdings (HCA) | 2.2 | $28M | -9% | 66k | 426.20 |
|
| CVS Caremark Corporation (CVS) | 2.0 | $26M | -27% | 347k | 75.39 |
|
| AmerisourceBergen (COR) | 1.9 | $25M | +51% | 81k | 312.53 |
|
| Outset Med Com New (OM) | 1.9 | $24M | +3% | 1.7M | 14.12 |
|
| Universal Hlth Svcs CL B (UHS) | 1.8 | $24M | NEW | 116k | 204.44 |
|
| Icon SHS (ICLR) | 1.8 | $23M | +51% | 134k | 175.00 |
|
| Centene Corporation (CNC) | 1.6 | $21M | NEW | 574k | 35.68 |
|
| Merck & Co (MRK) | 1.5 | $20M | NEW | 237k | 83.93 |
|
| Anthem (ELV) | 1.5 | $20M | NEW | 61k | 323.12 |
|
| Natera (NTRA) | 1.4 | $19M | +14% | 116k | 160.97 |
|
| Adma Biologics (ADMA) | 1.3 | $17M | NEW | 1.2M | 14.66 |
|
| Neogenomics Com New (NEO) | 1.3 | $17M | +186% | 2.2M | 7.72 |
|
| Bridgebio Pharma (BBIO) | 1.3 | $17M | -37% | 327k | 51.94 |
|
| Soleno Therapeutics (SLNO) | 1.3 | $17M | -40% | 243k | 67.60 |
|
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 1.2 | $16M | +93% | 666k | 24.25 |
|
| Ascendis Pharma A/s Note 2.250% 4/0 (Principal) | 1.2 | $16M | -49% | 12M | 1.36 |
|
| Oscar Health Cl A (OSCR) | 1.2 | $16M | +11% | 821k | 18.93 |
|
| Revolution Medicines (RVMD) | 1.2 | $16M | NEW | 331k | 46.70 |
|
| Vera Therapeutics Cl A (VERA) | 1.1 | $15M | NEW | 514k | 29.06 |
|
| Boston Scientific Corporation (BSX) | 1.1 | $15M | NEW | 151k | 97.63 |
|
| Spdr S&p 500 Etf Tr Tr Unit (SPY) | 1.1 | $14M | +23% | 21k | 666.18 |
|
| Ishares Tr Russell 2000 Etf Put Option (IWM) | 1.1 | $14M | NEW | 57k | 241.96 |
|
| Indivior Ord (INDV) | 1.0 | $14M | -58% | 562k | 24.11 |
|
| Veeva Sys Cl A Com (VEEV) | 1.0 | $12M | NEW | 42k | 297.91 |
|
| Merus N V (MRUS) | 0.9 | $12M | -28% | 131k | 94.15 |
|
| Akero Therapeutics (AKRO) | 0.9 | $12M | -6% | 248k | 47.48 |
|
| Regeneron Pharmaceuticals (REGN) | 0.9 | $11M | NEW | 20k | 562.27 |
|
| Irhythm Technologies (IRTC) | 0.9 | $11M | -26% | 65k | 171.99 |
|
| Compass Pathways Sponsored Ads (CMPS) | 0.7 | $9.5M | -6% | 1.7M | 5.73 |
|
| Waters Corporation (WAT) | 0.7 | $9.2M | -28% | 31k | 299.81 |
|
| Verona Pharma Sponsored Ads (VRNA) | 0.7 | $8.6M | 80k | 106.71 |
|
|
| Inhibrx Biosciences (INBX) | 0.6 | $8.1M | 240k | 33.68 |
|
|
| Neurocrine Biosciences (NBIX) | 0.6 | $8.0M | +346% | 57k | 140.38 |
|
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 0.6 | $7.2M | -71% | 357k | 20.20 |
|
| Arcutis Biotherapeutics (ARQT) | 0.5 | $6.8M | -60% | 361k | 18.85 |
|
| Cg Oncology (CGON) | 0.5 | $6.4M | NEW | 158k | 40.28 |
|
| Amylyx Pharmaceuticals (AMLX) | 0.5 | $5.9M | -40% | 436k | 13.59 |
|
| Cooper Cos (COO) | 0.4 | $5.1M | NEW | 74k | 68.56 |
|
| Rhythm Pharmaceuticals (RYTM) | 0.4 | $4.9M | NEW | 48k | 100.99 |
|
| Viking Therapeutics (VKTX) | 0.4 | $4.8M | +386% | 184k | 26.28 |
|
| West Pharmaceutical Services (WST) | 0.4 | $4.8M | NEW | 18k | 262.33 |
|
| Astrazeneca Sponsored Adr (AZN) | 0.4 | $4.7M | NEW | 62k | 76.72 |
|
| Argenx Se Sponsored Adr (ARGX) | 0.4 | $4.7M | -11% | 6.4k | 737.56 |
|
| Rezolute Com New (RZLT) | 0.3 | $4.3M | +4% | 453k | 9.40 |
|
| Syndax Pharmaceuticals (SNDX) | 0.3 | $3.9M | NEW | 257k | 15.38 |
|
| Mbx Biosciences (MBX) | 0.3 | $3.9M | NEW | 222k | 17.50 |
|
| Amneal Pharmaceuticals Com Stk Cl A (AMRX) | 0.3 | $3.6M | NEW | 356k | 10.01 |
|
| Structure Therapeutics Sponsored Ads (GPCR) | 0.2 | $3.2M | +103% | 115k | 28.00 |
|
| Praxis Precision Medicines I Com New (PRAX) | 0.2 | $3.2M | -28% | 61k | 53.00 |
|
| Enliven Therapeutics (ELVN) | 0.2 | $3.2M | NEW | 157k | 20.47 |
|
| Caribou Biosciences (CRBU) | 0.2 | $3.2M | 1.4M | 2.33 |
|
|
| Uniqure Nv SHS (QURE) | 0.2 | $2.7M | -73% | 46k | 58.37 |
|
| Dianthus Therapeutics (DNTH) | 0.2 | $2.7M | NEW | 68k | 39.35 |
|
| Disc Medicine (IRON) | 0.2 | $2.2M | +5% | 33k | 66.08 |
|
| Liquidia Corporation Com New Put Option (LQDA) | 0.1 | $1.7M | NEW | 76k | 22.74 |
|
| Hims & Hers Health Com Cl A (HIMS) | 0.1 | $1.3M | NEW | 23k | 56.72 |
|
| Thermo Fisher Scientific (TMO) | 0.1 | $1.1M | NEW | 2.3k | 485.02 |
|
| Mind Medicine Mindmed Com New (MNMD) | 0.1 | $886k | NEW | 75k | 11.79 |
|
| Werewolf Therapeutics (HOWL) | 0.1 | $790k | 401k | 1.97 |
|
Past Filings by PFM Health Sciences
SEC 13F filings are viewable for PFM Health Sciences going back to 2010
- PFM Health Sciences 2025 Q3 filed Nov. 14, 2025
- PFM Health Sciences 2025 Q2 filed Aug. 14, 2025
- PFM Health Sciences 2025 Q1 filed May 15, 2025
- PFM Health Sciences 2024 Q4 filed Feb. 14, 2025
- PFM Health Sciences 2024 Q3 filed Nov. 14, 2024
- PFM Health Sciences 2024 Q2 filed Aug. 14, 2024
- PFM Health Sciences 2024 Q1 filed May 14, 2024
- PFM Health Sciences 2023 Q4 filed Feb. 14, 2024
- PFM Health Sciences 2023 Q3 filed Nov. 14, 2023
- PFM Health Sciences 2023 Q2 filed Aug. 14, 2023
- PFM Health Sciences 2023 Q1 filed May 15, 2023
- PFM Health Sciences 2022 Q4 filed Feb. 14, 2023
- PFM Health Sciences 2022 Q3 filed Nov. 14, 2022
- PFM Health Sciences 2022 Q2 filed Aug. 15, 2022
- PFM Health Sciences 2022 Q1 filed May 16, 2022
- PFM Health Sciences 2021 Q4 filed Feb. 14, 2022